Evidence map›Paper›PMID 32504302›Full record

SynthesisPituitary2020

Ectopic GH-secreting pituitary adenoma of the clivus: systematic literature review of a challenging tumour.

Lucia Riccio, Carmine Antonio Donofrio, Giovanni Tomacelli, Roberto De Blasi, Alessandro Melatini

Abstract readCase ReportsSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Pituitary, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Growth hormone-releasing hormone, growth hormone, and neuroendocrine tumors.Journal of clinical & translational endocrinology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Lucia RiccioDepartment of Neurosurgery, Ospedale "Vito Fazzi", Piazza F. Muratore, 1, 73100, Lecce, Italy. dott.luciariccio@libero.it.ORCID http://orcid.org/0000-0002-8503-2196
Carmine Antonio DonofrioDepartment of Neurosurgery, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0002-9123-8158
Giovanni TomacelliENT Department, Ospedale "Vito Fazzi", Lecce, Italy.
Roberto De BlasiDepartment of Radiology, Azienda Ospedaliera "Cardinale Giovanni Panico", Tricase, Italy.
Alessandro MelatiniDepartment of Neurosurgery, Ospedale "Vito Fazzi", Piazza F. Muratore, 1, 73100, Lecce, Italy.
Ospedale Vito Fazzi · ITSalford Royal NHS Foundation Trust · GBVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAcromegaly is usually due to growth hormone (GH)-secreting pituitary adenomas, but it may be exceptionally caused by GH-secreting ectopic pituitary adenomas (EPA). EPA are defined as extra-sellar pituitary tumours, extra- or intra-cranially sited, entirely separated from the pituitary stalk and gland. The aim of the study is to address the challenges in the management of clival GHEPA.

methodsWe reported a case of a 53-year-old acromegalic patient with a primary clival GHEPA and reviewed systematically the relevant English literature between 1975 and 2019, in keeping with the PRISMA guidelines.

resultsFour cases of primary clival GHEPA have been described in literature apart from ours. All patients presented with acromegalic features, elevated circulating GH and/or insulin-like growth factor-1 levels. Hyperprolactinemia and empty sella were described in two cases, respectively. These tumours show the typical imaging characteristics of pituitary adenomas, but their neuroradiological diagnosis may be challenging due to their sizes and the difficulty in defining the absence of connections with the pituitary fossa.

conclusionAlthough primary clival GHEPA are exceedingly rare, even if likely under-reported in literature, they should be considered in the differential diagnosis of clival tumours because of their specific management. Surgery represents the first-line treatment option, while medical and radiation therapies can be adopted as neo-adjuvant, adjuvant or primary treatments according to tumour and patient characteristics.

Indexed as

Bone DiseasesChoristomaPituitary GlandAcromegalyAdenomaCranial Fossa, PosteriorEmpty Sella SyndromeGlucose Tolerance TestGrowth Hormone-Secreting Pituitary AdenomaHuman Growth HormoneHumansInsulin-Like Growth Factor IMaleMiddle AgedSkull Base NeoplasmsHuman Growth HormoneInsulin-Like Growth Factor IAcromegalyClival tumoursEctopic pituitary adenomaGrowth hormoneGrowth hormone-secreting adenomaRare tumours

Identifiers

PMID32504302
OpenAlexW3033389688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.